2022-04-11-世界卫生组织-Independent_Allocation_of_Vaccines_Group_IAVG_-_General_information_-_Phase_1_2页_300kb

COVAX Independent Allocation of Vaccines Group (IAVG) Summary

Core Content

The Independent Allocation of Vaccines Group (IAVG) is a key mechanism established by the World Health Organization (WHO) to ensure the fair, equitable, and transparent allocation of COVAX vaccines to participating countries and economies. It operates under the WHO Regulations for Study and Scientific Groups and is supported by the COVAX Partners (WHO, Gavi, and CEPI). The IAVG is tasked with reviewing and validating proposals for Vaccine Allocation Decisions ("VAD proposals") submitted by the Joint Allocation Taskforce (JAT), which is composed of WHO and Gavi staff.

Main Purpose

The primary objective of the IAVG is to validate VAD proposals that specify the volumes of vaccines to be allocated to each COVAX participant during a specific time period. This validation process is essential to ensure that the allocation decisions are technically sound, based on the latest data and evidence, and aligned with COVAX's mission of equitable vaccine distribution.

Main Functions of the IAVG

• Review and Clarification: The IAVG reviews the VAD proposals submitted by the JAT and requests clarifications when necessary.
• Discussion and Adjustment: It engages with the JAT to discuss and propose adjustments to the VAD proposals based on its critical assessment.
• Validation and Justification: The IAVG performs a validation assessment of the VAD proposals and documents its findings, including any adjustments made.
• Delivery to WHO: Once validated, the IAVG delivers the final VADs to the WHO Deputy-Director General for implementation by the JAT.

Key Information

• The IAVG is an independent body that supports the transparency and independence of the vaccine allocation decision-making process.
• The JAT is responsible for preparing the initial VAD proposals, which are then reviewed and validated by the IAVG.
• The allocation mechanism involves close collaboration between the IAVG, JAT, and the COVAX facility.
• The COVAX facility is responsible for implementing the final VAD decisions.
• UNICEF SD acts as the supply coordinator, while PAHO RF and self-procuring participants are involved in the operational execution.
• The JAT may also have the authority to check or modify the algorithm used in the allocation process.
• Exceptional operational adjustments can be made by UNICEF SD and PAHO RF based on rules set by the JAT.

Summary of the Allocation Process

1. The JAT prepares and submits a VAD proposal.
2. The IAVG reviews the proposal, requests clarifications, and discusses necessary adjustments.
3. The IAVG validates the VAD proposal and documents the rationale for any changes.
4. The validated VAD is delivered to the WHO Deputy-Director General for implementation.
5. The COVAX facility executes the allocation decision.
6. UNICEF SD coordinates the supply process, while PAHO RF and self-procuring participants handle operational aspects.
7. The JAT may adjust the allocation algorithm if needed, and exceptional operational changes can be made by UNICEF SD and PAHO RF based on JAT rules.

Conclusion

The IAVG plays a crucial role in ensuring the scientific integrity, transparency, and equity of the COVAX vaccine allocation process. It serves as an independent validator of the JAT's proposals, reinforcing the trustworthiness of the system and promoting global vaccine access.